Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T-Cell Receptor Alpha Beta+/CD19+ Depletion in Haploidentical Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Adult and Pediatric Patients With Hematological Malignancies and Non-malignant Disorders

NCT05236764 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT05236764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T-Cell Receptor Alpha Beta+/CD19+ Depletion in Haploidentical Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Adult and Pediatric Patients With Hematological Malignancies and Non-malignant Disorders
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 6, 2023
Completion date
May 23, 2027
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia in remission, acute myeloid leukemia in remission, bone marrow failure syndrome, chronic myeloid leukemia, cytopenia, hemoglobinopathies, hemophagocytic lymphohistiocytoses, myelodysplastic syndromes, primary immunodeficiency diseases, severe aplastic anemia, severe chronic active epstein-barr virus infection